9 completed, 1 terminated. 3 Phase 4, 2 Not applicable, 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Completed 3 |
| Not applicable | 2 | Completed 2 |
| Phase 2 | 2 | Completed 1, Terminated 1 |
| Phase 1 | 1 | Completed 1 |
Follow CF Therapeutics Development Network Coordinating Center: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Testing the Effect of Adding Chronic Oral Azithromycin to Inhaled Tobramycin in People With Cystic Fibrosis (CF) azithromycin, placebo (for azithromycin), inhaled tobramycin - Cystic Fibrosis | Phase 4 | Completed | Seattle Children's Hospital | 119 | 2016-10-21 | 2021-06-28 |
| Standardized Treatment of Pulmonary Exacerbations II Standard of care IV antibiotic(s) - Pulmonary Cystic Fibrosis | Phase 4 | Completed | Chris Goss | 982 | 2016-06-01 | 2021-05-19 |
| Early Methicillin-resistant Staphylococcus Aureus (MRSA) Therapy in Cystic Fibrosis (CF) Rifampin, Trimethoprim/Sulfamethoxazole, Minocycline - Cystic Fibrosis, Methicillin-resistant Staphylococcus Aureus | Phase 2 | Terminated | University of North Carolina, Chapel Hill | 47 | 2011-04-01 | 2017-05-15 |
| Detection of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Activity in Rectal Tissues From Human Subjects Cystic Fibrosis | Completed | CF Therapeutics Development Network Coordinating Center | 57 | 2009-10-01 | 2013-03-07 | |
| Infant Study of Inhaled Saline in Cystic Fibrosis 7% Hypertonic Saline (HS), 0.9% Isotonic Saline (IS) - Cystic Fibrosis | Not applicable | Completed | CF Therapeutics Development Network Coordinating Center | 321 | 2009-04-01 | 2013-02-12 |
| Tolerability of Inhaled Hypertonic Saline in Infants With Cystic Fibrosis inhaled 7% hypertonic saline (HS) - Cystic Fibrosis | Not applicable | Completed | CF Therapeutics Development Network Coordinating Center | 19 | 2007-09-01 | 2011-08-24 |
| Effect of Azithromycin on Lung Function in 6-18 Year-olds With Cystic Fibrosis (CF) Not Infected With P. Aeruginosa azithromycin 250 mg tablets, placebo tablets - Cystic Fibrosis | Phase 4 | Completed | CF Therapeutics Development Network Coordinating Center | 263 | 2007-02-01 | 2015-08-19 |
| Safety Study of Orally Administered Curcuminoids in Adult Subjects With Cystic Fibrosis standardized turmeric root extract - Cystic Fibrosis | Phase 1 | Completed | Ramsey, Bonnie, MD | 11 | 2005-04-01 | 2007-12-25 |
| The EPIC Observational Study Cystic Fibrosis | Completed | CF Therapeutics Development Network Coordinating Center | 1248 | 2004-10-01 | 2019-02-01 | |
| Comparison of Two Treatment Regimens to Reduce PA Infection in Children With Cystic Fibrosis Tobramycin solution for inhalation (TOBI), Oral placebo, Oral ciprofloxacin - Cystic Fibrosis, Pulmonary Disease, Chronic Obstructive | Phase 2 | Completed | Seattle Children's Hospital | 304 | 2004-09-01 | 2014-02-28 |
Cystic Fibrosis (10) · Infections (1) · Lung Diseases (1) · Pseudomonas Infections (1) · Pulmonary Disease, Chronic Obstructive (1)
Azithromycin (2) · Inhalation (2) · Saline Solution, Hypertonic (2) · Ciprofloxacin (1) · Minocycline (1) · Mupirocin (1) · Rifampin (1) · Saline Solution (1) · Sodium Chloride (1) · Tobramycin (1) · Trimethoprim, Sulfamethoxazole Drug Combination (1)
United States (10) · Canada (4)
Margaret Rosenfeld, MD, MPH (3) · Chris Goss, MD (2) · Felix Ratjen, MD, PhD (2) · Stephanie Davis, MD (2) · Bonnie W. Ramsey (1) · Chris Goss, MD, MSc (1) · David P Nichols, MD (1) · Felix Ratjen, MD (1) · George Retsch-Bogart, MD (1) · JP Clancy, MD (1) · Larry Lands, MD (1) · Lisa Saiman, MD, MPH (1) · Marianne S Muhlebach, MD (1) · Michael Anstead, MD (1) · Miriam Treggiari, MD (1)
PMID 19470318, PMID 20442386, PMID 20597081, PMID 21893650, PMID 22554417, PMID 22595153, PMID 22610452, PMID 23742699, PMID 25972024, PMID 26288390, PMID 27852955, PMID 34159577, PMID 34469706, PMID 34933824, PMID 35300932, PMID 36511181, PMID 37963297, PMID 38096105
R01HL124053 (1), U01HL080310 (1), U01HL092931 (1), U01HL092932 (1)